Pharmaceutical products for the treatment of hemophilia; pharmaceutical preparations and human vaccines for use in gene therapy and cell therapy; biological preparations for use in medical and clinical gene therapy and cell therapy for the treatment of hemophilia; clinical medical reagents for use in gene therapy, gene diagnosis and gene testing
REGISTERED
on 30 Nov 2022
HEMGENIX
CSL BEHRING L.L.C.
2019566 · 06 Feb 2020
005
Class 005
Pharmaceutical Products
Pharmaceutical products for the treatment of hemophilia; pharmaceutical preparations and human vaccines for use in gene therapy and cell therapy; biological preparations for use in medical and clinical gene therapy and cell therapy for the treatment of hemophilia; clinical medical reagents for use in gene therapy, gene diagnosis and gene testing
Pharmaceutical products for the treatment of hemophilia; pharmaceutica...
